5-95656258-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001131066.2(RFESD):āc.582C>Gā(p.Asp194Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,612,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001131066.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFESD | NM_001131066.2 | c.582C>G | p.Asp194Glu | missense_variant | 6/6 | ENST00000380005.9 | NP_001124538.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFESD | ENST00000380005.9 | c.582C>G | p.Asp194Glu | missense_variant | 6/6 | 2 | NM_001131066.2 | ENSP00000369341.4 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251078Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135764
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460852Hom.: 0 Cov.: 29 AF XY: 0.00000275 AC XY: 2AN XY: 726792
GnomAD4 genome AF: 0.000112 AC: 17AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.582C>G (p.D194E) alteration is located in exon 6 (coding exon 5) of the RFESD gene. This alteration results from a C to G substitution at nucleotide position 582, causing the aspartic acid (D) at amino acid position 194 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at